Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities
Open Access
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 131, 110701
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HHSN 261200800001E)
- Research Council of Finland (315824)
- Research Council of Finland (269341)
- Research Council of Finland (numbers315824,269341)
- Suomen Kulttuurirahasto
- National Cancer Institute
- National Institute on Aging
- Saastamoisen säätiö
This publication has 45 references indexed in Scilit:
- The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer MetabolismCell, 2012
- The sirtuin SIRT6 regulates lifespan in male miceNature, 2012
- Structures, Substrates, and Regulators of Mammalian Sirtuins – Opportunities and Challenges for Drug DevelopmentFrontiers in Pharmacology, 2012
- The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1αCell, 2010
- Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6Cell Cycle, 2009
- Gene expression, cell cycle arrest and MAPK signalling regulation in Caco‐2 cells exposed to ellagic acid and its metabolites, urolithinsMolecular Nutrition & Food Research, 2009
- SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatinNature, 2008
- SIRT6 in DNA repair, metabolism and ageingJournal of Internal Medicine, 2008
- N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- In vitro anti-proliferative activities of ellagic acidThe Journal of Nutritional Biochemistry, 2004